Hyperphagia clinical trials at UC Irvine
1 research study open to eligible people
open to eligible people ages 4-65
This Phase 2b/3 double-blind, placebo-controlled study will evaluate the safety, tolerability, and effects of livoletide on food-related behaviors in patients with Prader-Willi Syndrome (PWS).
Orange, California and other locations